Informations générales

310783048
8610Z
Centre Hospitalier Régional (C.H.R.)
31

Adresse

  BAT PIERRE PAUL RIQUET PL DU DR BAYLAC TSA 40031 31059 TOULOUSE CEDEX 9   Accès au plan

Listes des essais cliniques en recrutement

Etude Statut Dernière mise à jour
NCT03900221 French Registry for Monitoring Pregnancies and Children of Women With Multiple Sclerosis Within The Observatoire Français de la Sclérose en Plaque (OFSEP) Cohort (RESPONSE) En recrutement 13 mars 2025
NCT03464344 COrtical Superficial Siderosis and REcurrent Lobar Intracerebral Hemorrhage in Cerebral Amyloid Angiopathy. (CORELIA) En recrutement 28 août 2024
NCT04282473 Peristomal Hernia Rate 5 Years After a Terminal Colostomy With the Parietex ™ TCM Parietal Prosthesis Versus Without Mesh: Material-epidemiology Study (RESEDAE) En recrutement 20 mars 2023
NCT04103190 Multiparametric Imaging for Analysis of MVNT (Multinodular and Vacuolating Neuronal Tumor) (MIAM) En recrutement 20 mars 2023
NCT03867149 Involvement of the Mediodorsal Nucleus of the Thalamus in Higher Order Cognitive Processes : a Study in Patients With a Thalamic Infarct (THALEM2-0) Statut inconnu 20 mars 2023
NCT03773926 Neuro-feedback Therapy for Treating Tinnitus : Efficacy Pilot Study on a Targeted Population (TNTA) Statut inconnu 20 mars 2023
NCT01808911 Outcome of Acquired Haemophilia With Steroid Combined With Cyclophosphamide Versus Steroid Combined With Rituximab (CREHA Study) (CREHA) Statut inconnu 20 mars 2023
NCT01340235 Treatment of Dowling Maera Type of Epidermolysis Bullosa Simplex by Oral Erythromycin Statut inconnu 29 octobre 2022
NCT00808366 A Randomized, Parallel-Group, Multicentre, Open-Labelled, Active-Controlled Study to Assess the Efficacy, Safety and Tolerability of RV4104A Ointment Versus Bifonazole-Urea Ointment for the Complete Removal of the Clinically Infected Nail Plate Area in Patients With Toenail Onychomycosis Statut inconnu 29 octobre 2022
NCT00443339 A Phase II Study of Darbepoetin Alpha in Myelodysplastic Syndromes (MSD) Statut inconnu 29 octobre 2022
NCT00424229 Phase II Study of the Efficacy and Safety of Lenalidomide in Adult Subjects With Intermediate-2-or Higt Risk Myelodysplastic Syndrome(MDS) Associated With a Deletion (DEL) 5q [31] Statut inconnu 29 octobre 2022